Raymond James Financial Inc Neurocrine Biosciences Inc Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 843,902 shares of NBIX stock, worth $128 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
843,902Holding current value
$128 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.15 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.51 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$778 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$389 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$282 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...